Rajamanickam Vinothkumar Selected Research

Carcinogenesis

1/2021	Pharmacological inhibition of MELK restricts ferroptosis and the inflammatory response in colitis and colitis-propelled carcinogenesis.
1/2018	A mono-carbonyl analog of curcumin induces apoptosis in drug-resistant EGFR-mutant lung cancer through the generation of oxidative stress and mitochondrial dysfunction.
9/2014	Chemopreventive effect of zingerone against colon carcinogenesis induced by 1,2-dimethylhydrazine in rats.
2/2014	Modulatory effect of troxerutin on biotransforming enzymes and preneoplasic lesions induced by 1,2-dimethylhydrazine in rat colon carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rajamanickam Vinothkumar Research Topics

Disease

4	Carcinogenesis 01/2021 - 02/2014
4	Neoplasms (Cancer) 01/2021 - 12/2016
3	Colonic Neoplasms (Colon Cancer) 12/2016 - 03/2012
2	Stomach Neoplasms (Stomach Cancer) 12/2021 - 12/2016
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2018 - 12/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018 - 01/2017
2	Aberrant Crypt Foci 09/2014 - 02/2014
1	Type 2 Diabetes Mellitus (MODY) 09/2021
1	Inflammation (Inflammations) 01/2021
1	Colitis 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 12/2016

Drug/Important Bio-Agent (IBA)

2	Sirolimus (Rapamycin)FDA Link 12/2021 - 12/2016
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2018 - 12/2016
2	CurcuminIBA 01/2018 - 12/2016
2	Dimenhydrinate (DMH)FDA LinkGeneric 09/2014 - 02/2014
2	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 09/2014 - 02/2014
1	FluorocarbonsIBA 09/2021
1	1- (6- (3,5- dichloro- 4- hydroxyphenyl)- 4- ((4- ((dimethylamino)methyl)cyclohexyl)amino)- 1,5- naphthyridin- 3- yl)ethanoneIBA 01/2021
1	WZ35 compoundIBA 01/2018
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2018
1	Gefitinib (Iressa)FDA Link 01/2018
1	Tyrosine Kinase InhibitorsIBA 01/2018
1	ErbB Receptors (EGF Receptor)IBA 01/2018
1	CrizotinibIBA 01/2017
1	TOR Serine-Threonine KinasesIBA 12/2016
1	JNK Mitogen-Activated Protein KinasesIBA 12/2016
1	Cytochromes c (Cytochrome c)IBA 12/2016
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 09/2014
1	Thiobarbituric Acid Reactive SubstancesIBA 09/2014
1	Hydroxyl RadicalIBA 09/2014
1	AntioxidantsIBA 09/2014
1	Glutathione Reductase (Glutathione-Disulfide Reductase)IBA 09/2014
1	LipidsIBA 09/2014
1	Superoxide DismutaseIBA 09/2014
1	CatalaseIBA 09/2014
1	Vitamin E FDA LinkGeneric 09/2014
1	zingeroneIBA 09/2014
1	Glutathione PeroxidaseIBA 09/2014
1	Glutathione (Reduced Glutathione)IBA 09/2014
1	troxerutinIBA 02/2014
1	XenobioticsIBA 02/2014
1	EnzymesIBA 02/2014
1	FlavonoidsIBA 03/2012
1	hesperetinIBA 03/2012

Therapy/Procedure

2	Therapeutics 01/2018 - 12/2016
1	Fecal Microbiota Transplantation 01/2021